Literature DB >> 9298867

Complete remission in three patients with acute myeloblastic leukemia by administration of G-CSF without antileukemic agents.

M Takahashi1, T Koike, Y Aizawa, M Kashimura, K Hayatsu, K Nagai, A Abe, M Urushiyama, K Yagisawa.   

Abstract

We describe 3 patients with acute myeloblastic leukemia (AML), who received rhG-CSF for infections such as pneumonia or for prophylaxis of infection, and who achieved complete remission. They had not received any antileukemic therapy before or during the administration of rhG-CSF. These findings suggest the possibility that complete remission can be brought about by G-CSF itself in some patients with AML.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298867     DOI: 10.1002/(sici)1096-8652(199709)56:1<42::aid-ajh9>3.0.co;2-2

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Severe systemic infection masking underlying childhood leukemia.

Authors:  Aruna Rajendran; Amita Trehan; Jasmina Ahluwalia; Ram Kumar Marwaha
Journal:  Indian J Hematol Blood Transfus       Date:  2012-07-25       Impact factor: 0.900

2.  Does Development of Plasmacytosis have a Role in Spontaneous Remission of Acute Myeloid Leukemia?

Authors:  Nishant Jindal; Ram Nampoothiri; Sweta Rajpal; Sreejesh Sreedharanunni; Neelam Varma; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2020-06-04       Impact factor: 0.900

3.  Clinical Characteristics of Bloodstream Infections in Pediatric Acute Leukemia: A Single-center Experience with 231 Patients.

Authors:  Jia-Feng Yao; Nan Li; Jin Jiang
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

4.  Mathematical modeling of the impact of cytokine response of acute myeloid leukemia cells on patient prognosis.

Authors:  Thomas Stiehl; Anthony D Ho; Anna Marciniak-Czochra
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.